Incidence rates and risk factors for owner-reported adverse events following vaccination of dogs that did or did not receive a Leptospira vaccine

Peng Ju Yao, Nicole Stephenson, Janet E Foley, Chuck R. Toussieng, Thomas B Farver, Jane E Sykes, Katryna A. Fleer

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective—To determine incidence rates (IRs) and potential risk factors for owner-reported adverse events (AEs) following vaccination of dogs that did or did not receive a Leptospira vaccine. Design—Observational, retrospective cohort study. Animals—130,557 dogs. Procedures—Electronic records of mobile veterinary clinics from June 2012 to March 2013 were searched to identify dogs that received ≥ 1 vaccine in a given visit. Signalment data, vaccinations received, medications administered, and owner-reported clinical signs consistent with AEs that developed ≤ 5 days after vaccination were recorded. Associations between potential risk factors and owner-reported AEs were evaluated by logistic regression analysis. Results—The IR/10,000 dogs for owner-reported postvaccination AEs was 26.3 (95% CI, 23.6 to 29.2), whereas that for dogs that received a Leptospira vaccine alone or with other vaccines was 53.0 (95% CI, 42.8 to 64.9). Significant factors for increasing or decreasing risk of AEs were as follows: receiving a Leptospira vaccine (adjusted OR, 2.13), age at vaccination 1 to <7 or ≥ 7 years (vs a referent of <6 months; adjusted OR, 0.54 and 0.44, respectively), and weight 13.6 to <22.7 kg (30 to <50 lb) and 22.7 to <45.5 kg (50 to 100 lb [vs a referent of <4.5 kg {10 lb}]; adjusted OR, 0.48 and 0.55, respectively). Hypersensitivity reactions were rare (IR, 6.5/10,000 dogs), and IRs for these events did not differ significantly between dogs vaccinated with or without a Leptospira component. Conclusions and Clinical Relevance—The overall IR for owner-reported postvaccination AEs was low. Results suggested vaccination against Leptospira (an organism that can cause fatal disease) is safe in the majority of cases, slightly increasing the risk of owner-reported AEs but not associated with a significant increase in hypersensitivity reactions, compared with other vaccinations administered.

Original languageEnglish (US)
Pages (from-to)1139-1145
Number of pages7
JournalJournal of the American Veterinary Medical Association
Volume247
Issue number10
DOIs
StatePublished - Nov 15 2015

Fingerprint

Leptospira
Vaccination
risk factors
Vaccines
vaccination
Dogs
vaccines
incidence
dogs
Incidence
hypersensitivity
Hypersensitivity
Mobile Health Units
Animal Hospitals
veterinary clinics
cohort studies
drug therapy
Cohort Studies
regression analysis
Retrospective Studies

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Incidence rates and risk factors for owner-reported adverse events following vaccination of dogs that did or did not receive a Leptospira vaccine. / Yao, Peng Ju; Stephenson, Nicole; Foley, Janet E; Toussieng, Chuck R.; Farver, Thomas B; Sykes, Jane E; Fleer, Katryna A.

In: Journal of the American Veterinary Medical Association, Vol. 247, No. 10, 15.11.2015, p. 1139-1145.

Research output: Contribution to journalArticle

@article{ebceb3ef3a2f4fb19e0bff16247b655c,
title = "Incidence rates and risk factors for owner-reported adverse events following vaccination of dogs that did or did not receive a Leptospira vaccine",
abstract = "Objective—To determine incidence rates (IRs) and potential risk factors for owner-reported adverse events (AEs) following vaccination of dogs that did or did not receive a Leptospira vaccine. Design—Observational, retrospective cohort study. Animals—130,557 dogs. Procedures—Electronic records of mobile veterinary clinics from June 2012 to March 2013 were searched to identify dogs that received ≥ 1 vaccine in a given visit. Signalment data, vaccinations received, medications administered, and owner-reported clinical signs consistent with AEs that developed ≤ 5 days after vaccination were recorded. Associations between potential risk factors and owner-reported AEs were evaluated by logistic regression analysis. Results—The IR/10,000 dogs for owner-reported postvaccination AEs was 26.3 (95{\%} CI, 23.6 to 29.2), whereas that for dogs that received a Leptospira vaccine alone or with other vaccines was 53.0 (95{\%} CI, 42.8 to 64.9). Significant factors for increasing or decreasing risk of AEs were as follows: receiving a Leptospira vaccine (adjusted OR, 2.13), age at vaccination 1 to <7 or ≥ 7 years (vs a referent of <6 months; adjusted OR, 0.54 and 0.44, respectively), and weight 13.6 to <22.7 kg (30 to <50 lb) and 22.7 to <45.5 kg (50 to 100 lb [vs a referent of <4.5 kg {10 lb}]; adjusted OR, 0.48 and 0.55, respectively). Hypersensitivity reactions were rare (IR, 6.5/10,000 dogs), and IRs for these events did not differ significantly between dogs vaccinated with or without a Leptospira component. Conclusions and Clinical Relevance—The overall IR for owner-reported postvaccination AEs was low. Results suggested vaccination against Leptospira (an organism that can cause fatal disease) is safe in the majority of cases, slightly increasing the risk of owner-reported AEs but not associated with a significant increase in hypersensitivity reactions, compared with other vaccinations administered.",
author = "Yao, {Peng Ju} and Nicole Stephenson and Foley, {Janet E} and Toussieng, {Chuck R.} and Farver, {Thomas B} and Sykes, {Jane E} and Fleer, {Katryna A.}",
year = "2015",
month = "11",
day = "15",
doi = "10.2460/javma.247.10.1139",
language = "English (US)",
volume = "247",
pages = "1139--1145",
journal = "Journal of the American Veterinary Medical Association",
issn = "0003-1488",
publisher = "American Veterinary Medical Association",
number = "10",

}

TY - JOUR

T1 - Incidence rates and risk factors for owner-reported adverse events following vaccination of dogs that did or did not receive a Leptospira vaccine

AU - Yao, Peng Ju

AU - Stephenson, Nicole

AU - Foley, Janet E

AU - Toussieng, Chuck R.

AU - Farver, Thomas B

AU - Sykes, Jane E

AU - Fleer, Katryna A.

PY - 2015/11/15

Y1 - 2015/11/15

N2 - Objective—To determine incidence rates (IRs) and potential risk factors for owner-reported adverse events (AEs) following vaccination of dogs that did or did not receive a Leptospira vaccine. Design—Observational, retrospective cohort study. Animals—130,557 dogs. Procedures—Electronic records of mobile veterinary clinics from June 2012 to March 2013 were searched to identify dogs that received ≥ 1 vaccine in a given visit. Signalment data, vaccinations received, medications administered, and owner-reported clinical signs consistent with AEs that developed ≤ 5 days after vaccination were recorded. Associations between potential risk factors and owner-reported AEs were evaluated by logistic regression analysis. Results—The IR/10,000 dogs for owner-reported postvaccination AEs was 26.3 (95% CI, 23.6 to 29.2), whereas that for dogs that received a Leptospira vaccine alone or with other vaccines was 53.0 (95% CI, 42.8 to 64.9). Significant factors for increasing or decreasing risk of AEs were as follows: receiving a Leptospira vaccine (adjusted OR, 2.13), age at vaccination 1 to <7 or ≥ 7 years (vs a referent of <6 months; adjusted OR, 0.54 and 0.44, respectively), and weight 13.6 to <22.7 kg (30 to <50 lb) and 22.7 to <45.5 kg (50 to 100 lb [vs a referent of <4.5 kg {10 lb}]; adjusted OR, 0.48 and 0.55, respectively). Hypersensitivity reactions were rare (IR, 6.5/10,000 dogs), and IRs for these events did not differ significantly between dogs vaccinated with or without a Leptospira component. Conclusions and Clinical Relevance—The overall IR for owner-reported postvaccination AEs was low. Results suggested vaccination against Leptospira (an organism that can cause fatal disease) is safe in the majority of cases, slightly increasing the risk of owner-reported AEs but not associated with a significant increase in hypersensitivity reactions, compared with other vaccinations administered.

AB - Objective—To determine incidence rates (IRs) and potential risk factors for owner-reported adverse events (AEs) following vaccination of dogs that did or did not receive a Leptospira vaccine. Design—Observational, retrospective cohort study. Animals—130,557 dogs. Procedures—Electronic records of mobile veterinary clinics from June 2012 to March 2013 were searched to identify dogs that received ≥ 1 vaccine in a given visit. Signalment data, vaccinations received, medications administered, and owner-reported clinical signs consistent with AEs that developed ≤ 5 days after vaccination were recorded. Associations between potential risk factors and owner-reported AEs were evaluated by logistic regression analysis. Results—The IR/10,000 dogs for owner-reported postvaccination AEs was 26.3 (95% CI, 23.6 to 29.2), whereas that for dogs that received a Leptospira vaccine alone or with other vaccines was 53.0 (95% CI, 42.8 to 64.9). Significant factors for increasing or decreasing risk of AEs were as follows: receiving a Leptospira vaccine (adjusted OR, 2.13), age at vaccination 1 to <7 or ≥ 7 years (vs a referent of <6 months; adjusted OR, 0.54 and 0.44, respectively), and weight 13.6 to <22.7 kg (30 to <50 lb) and 22.7 to <45.5 kg (50 to 100 lb [vs a referent of <4.5 kg {10 lb}]; adjusted OR, 0.48 and 0.55, respectively). Hypersensitivity reactions were rare (IR, 6.5/10,000 dogs), and IRs for these events did not differ significantly between dogs vaccinated with or without a Leptospira component. Conclusions and Clinical Relevance—The overall IR for owner-reported postvaccination AEs was low. Results suggested vaccination against Leptospira (an organism that can cause fatal disease) is safe in the majority of cases, slightly increasing the risk of owner-reported AEs but not associated with a significant increase in hypersensitivity reactions, compared with other vaccinations administered.

UR - http://www.scopus.com/inward/record.url?scp=84945976705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945976705&partnerID=8YFLogxK

U2 - 10.2460/javma.247.10.1139

DO - 10.2460/javma.247.10.1139

M3 - Article

VL - 247

SP - 1139

EP - 1145

JO - Journal of the American Veterinary Medical Association

JF - Journal of the American Veterinary Medical Association

SN - 0003-1488

IS - 10

ER -